Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
10/1999
10/26/1999US5972993 Using mixture of antioxidant, phenolic compound, sulfur containing compound and polyene
10/26/1999US5972990 Administering angiotensin ii inhibitors, such as losartan to patients who are otherwise free of indications for angiotensin ii inhibition treatment and have left ventricular ejection fraction of 40% or less
10/26/1999US5972933 Method of treating microbial infections
10/26/1999US5972928 Administering an antigrowth agent
10/26/1999US5972923 Methods and compositions to enhance the cytoprotective effects of polycyclic phenolic compounds through the synergistic interaction with anti-oxidants
10/26/1999US5972921 Use of an aromatase inhibitor in the treatment of decreased androgen to estrogen ratio and detrusor urethral sphincter dyssynergia in men
10/26/1999US5972919 Combination of a bronchodilator and a steroidal anti-inflammatory drug for the treatment of respiratory disorders, as well as its use and the preparation thereof
10/26/1999US5972906 Administering topically an effective amount of antiinflammatory agent/non-steroid/ and a form of hyaluronic acid selected from hyaluronic acid or salts
10/26/1999US5972903 Method for promoting angiogenesis using heparin and adenosine
10/26/1999US5972896 Antiangiogenic peptides and methods for inhibiting angiogenesis
10/26/1999US5972881 Treating NIDDM with RXR agonists
10/26/1999US5972674 May be used, for example, to identify antibodies and other agents that inhibit or activate signal transduction via the nf-.kappa.b cascade.
10/26/1999US5972651 Polynucleotides and polypeptides of the fifty-four homologue family, (ffh); vectors and transformed host cells; ffh are components of protein secretory apparatus and their inhibition of function is deleterious to bacteria cells
10/26/1999US5972636 ATP-dependent protease and use of inhibitors for same in the treatment of cachexia and muscle wasting
10/26/1999US5972598 Methods for preventing multidrug resistance in cancer cells
10/26/1999US5972367 A sugar, amino acids, electrolytes and a fat emulsion for nutrient supply use.
10/26/1999US5972338 ?tie? or ?tie? are acronyms, which stand for ?tyrosine kinase containing ig and egf homology domains?; present invention concerns novel human tie ligand homologues with powerful effects on vasculature; antitumor agents
10/26/1999CA2132993C Physiologically active substance
10/21/1999WO1999053077A1 Novel nep ii membrane metalloprotease and its use for screening inhibitors useful in therapy
10/21/1999WO1999053060A2 Glaucoma therapeutics and diagnostics based on a novel human transcription factor
10/21/1999WO1999053043A2 Herpes simplex virus latency associated transcript polypeptides
10/21/1999WO1999053032A1 TRANSGENIC MAMMALS EXPRESSING MUTANT GP IIIa
10/21/1999WO1999053020A1 6-phosphogluconate dehydrogenase of streptococcus pneumoniae
10/21/1999WO1999052938A2 Identification of chemical active agents for inhibiting the 1-desoxy-d-xylulose-5-phosphate biosynthetic pathway in parasites
10/21/1999WO1999052929A1 Nucleic acid sequences and proteins associated with aging
10/21/1999WO1999052926A1 Regulated target expression for screening
10/21/1999WO1999052877A1 Receptor ligands
10/21/1999WO1999052858A2 Lipids
10/21/1999WO1999052562A2 Enhancement of antibody-cytokine fusion protein mediated immune responses by co-administration with angiogenesis inhibitor
10/21/1999WO1999052559A1 OPHTHALMIC COMPOSITION COMPRISING A β-BLOCKER
10/21/1999WO1999052555A1 Methods and compositions using norastemizole in combination with leukotriene inhibitors
10/21/1999WO1999052554A1 Methods and compositions using terfenadine metabolites in combination with leukotriene inhibitors
10/21/1999WO1999052553A1 Methods and compositions using cetirizine in combination with leukotriene inhibitors for treating conditions responsive to leukotriene inhibition
10/21/1999WO1999052552A1 T cell inhibitory receptor compositions and uses thereof
10/21/1999WO1999052541A2 Artery- and vein-specific proteins and uses therefor
10/21/1999WO1999052538A1 Composition containing a herbal medicinal substance and a pharmaceutical drug
10/21/1999WO1999052519A2 Methods for treating neuropsychiatric disorders
10/21/1999WO1999052516A2 Acylpeptide protease inhibitors to enhance cognitive function
10/21/1999WO1999052507A1 Incorporation of active substances in carrier matrixes
10/21/1999WO1999046379A3 Human receptor proteins; related reagents and methods
10/21/1999WO1999045920A3 The use of a protein tyrosine inhibitor such as genistein in the treatment of diabetic retinopathy or ocular inflammation
10/21/1999WO1999045905A3 Prophylaxis and treatment of migraine headaches with thromboxane synthetase inhibitors and/or receptor antagonists
10/21/1999WO1999042593A8 Compositions and methods for sensitizing and inhibiting growth of human tumor cells
10/21/1999WO1999038501A9 Method of regulating glucose metabolism, and reagents related thereto
10/21/1999WO1999033870A3 Human regulatory proteins
10/21/1999WO1999030738A3 Diagnostics and therapeutics for transmissible spongiform encephalopathy and methods for the manufacture of non-infective blood products and tissue derived products
10/21/1999WO1995026768A9 Methods for treating pulmonary vasoconstriction and asthma
10/21/1999CA2328725A1 T cell inhibitory receptor compositions and uses thereof
10/21/1999CA2328360A1 Improvements in or relating to protease inhibitors
10/21/1999CA2328252A1 Receptor ligands
10/21/1999CA2328157A1 Method for identifying chemical active agents and active agents for inhibiting the 1-desoxy-d-xylulose-5-phosphate biosynthetic pathway
10/21/1999CA2328075A1 Methods and compositions using norastemizole in combination with leukotriene inhibitors
10/21/1999CA2325817A1 Transgenic mammals expressing mutant gp iiia
10/21/1999CA2325602A1 Regulated target expression for screening
10/21/1999CA2325599A1 Novel nep ii membrane metalloprotease and its use for screening inhibitors useful in therapy
10/21/1999CA2325563A1 Artery- and vein-specific proteins and uses therefor
10/21/1999CA2324480A1 Glaucoma therapeutics and diagnostics based on a novel human transcription factor
10/21/1999CA2323934A1 Nucleic acid sequences and proteins associated with aging
10/20/1999EP0950417A2 Treatment of skeletal disorders
10/20/1999EP0950406A2 Remedy for CAG repeat expansion diseases
10/20/1999EP0950104A1 NOVEL FELINE Fc EPSILON RECEPTOR ALPHA CHAIN NUCLEIC ACID MOLECULES, PROTEINS AND USES THEREOF
10/20/1999EP0950099A1 NOVEL flt-3 RECEPTOR AGONISTS
10/20/1999EP0950092A2 Parasitic nematode transglutaminase proteins, nucleic acid molecules, and uses thereof
10/20/1999EP0950059A1 Cyclic sulfone derivatives
10/20/1999EP0949931A1 Combination therapy using an il-1 inhibitor for treating il-1 mediated diseases
10/20/1999EP0949922A1 Pharmaceutical compositions and methods of treating compulsive disorders using naaladase inhibitors
10/20/1999EP0949919A1 A process for stabilizing levogyre ascorbic acid (laa) and stable laa compositions
10/20/1999EP0949917A1 Substances and their uses
10/20/1999EP0949904A1 Pharmaceutical compositions
10/20/1999EP0949865A1 The use of cd4-binding small molecules to inhibit immune responses
10/20/1999EP0767660B1 Methods and formulations for modulating the human sexual response
10/20/1999EP0643581B1 Ocular androgen therapy in sjögren's syndrome
10/20/1999CN1232501A Modified TIE-2 -receptor ligands
10/20/1999CN1232499A Human growth gene and short stature gene region
10/20/1999CN1232498A Guanine exchange factor of RHO GTPase and nucleic acid encoding it
10/20/1999CN1232497A AGE-1 polypeptides and related molecules and methods
10/20/1999CN1232462A Muscarinic antagonists
10/20/1999CN1232453A Ether muscarinic antagonists
10/20/1999CN1232397A Use of H+, K+-ATPase inhibitor in treatment of nasal polyps
10/19/1999US5969105 Stem cell factor receptor agonists
10/19/1999US5969017 Methods of treating or preventing cardiac arrhythmia
10/19/1999US5968983 Administering a mixture of arginine and an inhibitor of a reductase
10/19/1999US5968972 Administering a cyclosporin and paclitaxel or salt
10/19/1999US5968963 PLA2 inhibitors and their use for inhibition of intestinal cholesterol absorption
10/19/1999US5968959 Administering phospholamban inhibitor
10/19/1999US5968921 Compositions and methods for promoting nerve regeneration
10/19/1999US5968914 Treatment of chemotherapeutic agent and antiviral agent toxicity with acylated pyrimidine nucleosides
10/19/1999US5968910 Two or three compounds which do not select for same mutantstrains; preventtion or treatment of htlv infections
10/19/1999US5968903 Helicobacter and antigrowth agents, using somatostatin or agonist
10/19/1999US5968825 Antisense oligonucleotides complementary to the primary transcript of the human c-fes protooncogene
10/19/1999US5968824 Administering agent which modulates biochemical pathway in which products of opioid peptide precursor genes participate; antitumor agents; prevention of opacity of intraocular lens after cataract surgery
10/19/1999US5968819 DNA encoding a hypothalamic atypical neuropeptide Y/peptide YY receptor (Y5)
10/19/1999US5968777 DNA encoding seryl t-RNA synthetase
10/19/1999US5968752 Method for identifying an OP-1 analog which binds an ALK-1 receptor
10/19/1999US5968747 Polynucleotide encoding polypeptide; therapy for prevention and treatment of cancer, autoimmune diseases, developmental defects, nervous system disorders
10/19/1999US5968737 Method of identifying inhibitors of glutathione S-transferase (GST) gene expression
10/19/1999US5968542 Surgical implants; noncrystallizing carrier
10/19/1999CA2154913C Magnetically responsive composition for carrying biologically active substances and methods of production and use
10/14/1999WO1999051742A2 Dadd, death activator death domain protein
10/14/1999WO1999051735A2 Mapkap kinase 2-inhibitors and the use thereof in anti-inflammatory therapy
1 ... 1003 1004 1005 1006 1007 1008 1009 1010 1011 1012 1013 1014 1015 1016 1017 1018 1019 1020 1021 1022 1023 ... 1151